Aim
The aim of the study was to explore whether hexokinase 1 (HK1) is involved in the inhibition of inflammation mediated by nucleotideâbinding oligomerization domainâlike receptor protein 3 (NLRP3) signalling pathway in the development of apical periodontitis (AP).
Methodology
Human AP tissues and normal control tissues were collected in the clinic. First, the levels of glucose, pyruvate, lactate and hexokinase activity were examined in human AP tissues. ECAR and OCR were further measured to detect the level of glycolysis in vitro model of inflammation, which established with lipopolysaccharide (LPS)âstimulated RAW264.7 cell line. Secondly, the expression of HK1, NLRP3, caspaseâ1 and interleukin (IL)â1β were measured by Western blot, immunohistochemistry or RTâqPCR. Finally, lentiviral short hairpin RNA (shRNA) silencing technique or the inhibitor 2âdeoxyâdâglucose (2âDG) were used to further detect the relationship between HK1âmediated glycolysis and NLRP3âmediated inflammation in the development of AP in vitro.
Results
Initially, the level of glycolysis was significantly increased in human AP tissues. Subsequently, the expression of HK1, NLRP3, caspaseâ1 and ILâ1β were upregulated significantly in human AP tissues. Furthermore, in the model of AP in vitro, a high level of glycolysis and the high expression of HK1, NLRP3, caspaseâ1 and ILâ1β was observed. Finally, the expression of NLRP3, caspaseâ1 and ILâ1β mediated by LPS stimulation was significantly reduced via HK1 knockdown or 2âDG treatment in vitro.
Conclusions
Our data support that HK1âmediated glycolysis plays a crucial role in the development of AP via upregulating the NLRP3 signalling pathway. Moreover, targeting HK1 may contribute to prevent the progression of AP, which has a potential clinical translation.